FAST (Centre for Future Affordable Sustainable Therapy Development) is excited to announce on behalf of the Dutch Ministry of Health, NWO and ZonMw the upcoming stakeholder meeting, dedicated to advancing innovative antimicrobial therapy development. This event aims to bring together stakeholders from academia, industry, governmental organizations, research funding organizations and all other relevant bodies and organizations, in hopes of fostering research, development, and production of new antimicrobial agents and enrich the innovation ecosystem for innovative antimicrobial therapies. Register here
We welcome you on Tuesday, January 30th 2024 from 11:30 – 18:00 at the Jaarbeurs Meetup in Utrecht.
Program
The program will include plenary sessions and thematic breakout sessions surrounding several aspects of antimicrobial therapy, such as novel clinical development models, push and pull mechanisms and repurposing drugs for antimicrobial use. Importantly, the event will mark the launch of a new AMR research program by NWO (expected to launch mid-January 2024) to stimulate research and development of novel antimicrobials against bacteria and fungi for human use. The program will offer matchmaking opportunities to prepare the formation of relevant public-private consortia for the research program. The meeting will be held in English.
Preliminary program
11:30 – 12:00 Reception with lunch
12:00 -12:10 Welcome and introduction by chairman Mark Wijsman
12:10 – 13:30 Plenary session: Stimulating antimicrobial therapy development
- Setting the stage by the Dutch Ministry of Health, Karla van Rooijen (director of the department of Medicines and Medical Technology) and introductions Prof. dr. Gilles van Wezel (Leiden University)
- Stimulating antimicrobial therapy development by Dr. Titia Plantiga (NWO) and Dr. Vincent van Hensbergen (NWO) and Steven Marinus (Ministry of Health, Welfare and Sport)
- Public-private partnership for antimicrobial therapy development by Jon de Vlieger, Lygature
13:30 – 14:00 Matchmaking sessions
14:00 – 14:15 Break
14:15 – 15:15 Break-out sessions
- Clinical development of antimicrobial agent
Moderated by Dr. Saco de Visser (Chief Science Officer, FAST)
Speakers: Prof dr. Meta Roestenberg (Leiden University Medical Center) and Prof dr. Marc Bonten (Chief Executive Officer ECRAID, University Medical Center Utrecht). - Opportunities for repurposing and innovations in existing antimicrobial therapies
Moderated by Prof dr. Dick de Zeeuw (Chairman Drug Repurposing committee ZonMw, UMCG)
Speakers: Dr. Martin de Kort (Senior Scientific Program Manager Translational Medicine & Drug Development, EATRIS) and Dr. Edwin Spaans (Principle Consultant, CURARE). - Novel solutions for the prevention, diagnosis and treatment of antimicrobial infections
Moderated by Annemiek Verkamman (Managing Director, HollandBIO)
Speakers: Dr. Sophia E. Shanko (CEO, ShanX Medtech), Dr. Pol Vandenbroucke (VP Global Government Affairs, Shionogi) and Dr. Remko van Leeuwen (CEO, SurvivX, Beam Alliance).
15:15 – 15:30 Break
15:30 – 17:00 Plenary session: International developments
- Global Antibiotic Research and Development Partnership (GARDP)
- Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator (CARB-X)
- Health Emergency Preparedness and Response Authority (HERA)
17:00-18:00 Networking
Registration
Given the expected interest and moderate capacity (about 100 persons), please register now to ensure your participation.
We hope to welcome you on January 30th.
Together, we can make a profound impact on the future of antimicrobial therapy development.